Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-01 · accession 0001127602-24-014299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-06 | 2024-05-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +108.1K | 930.5K | +13% | — |
| D | 2024-05-06 | 2024-05-02 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $0.85 | -47.8K | 925.4K | -5% | -$40.6K |
| DM | 2024-05-06 | 2024-05-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -108.1K | 616.2K | -15% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-01 | M | A | 1,635 | — | 973,206 | D | — | — | (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 2 | Common | Class A Common Stock | 2024-05-01 | M | A | 22,917 | — | 971,571 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 3 | Common | Class A Common Stock | 2024-05-01 | M | A | 18,125 | — | 948,654 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 4 | Common | Class A Common Stock | 2024-05-02 | S | D | 47,806 | $0.85 | 925,400 | D | — | — | |
| 5 | Common | Class A Common Stock | 2024-05-01 | M | A | 65,450 | — | 930,529 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 6 | Derivative | Restricted Stock Units | 2024-05-01 | M | D | 22,917 | — | 1,054,167 | D | — · — to — | 22,917 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F6) The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |
| 7 | Derivative | Class B Common Stock | 2024-05-01 | M | D | 1,635 | — | 627,050 | D | — · — to — | 1,635 Class A Common Stock | (F7) Includes shares of Class B Common Stock that are subject to vesting conditions. (F3) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 8 | Derivative | Restricted Stock Units | 2024-05-01 | M | D | 65,450 | — | 646,986 | D | — · — to — | 65,450 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 9 | Derivative | Restricted Stock Units | 2024-05-01 | M | D | 18,125 | — | 616,250 | D | — · — to — | 18,125 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F5) The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |